2-(3-(Benzyloxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 10g

2-Hydroxy-1,2-diphenylethanone oxime, 95.0%, 500g

(R)-4-Isopropyl-2-(6-methylpyridin-2-yl)-4,5-dihydrooxazole, 98%, 100mg

Larotrectinib, 97%, 10mg

1,2,3,4-Tetrahydro-1,6-naphthyridine-8-carbonitrile, 98%, 100mg

1-(4-Chlorophenyl)-2-methylpropan-1-amine hydrochloride, 95.0%, 1g

5-Bromo-2-naphthoic acid, 97.0%, 1g

Ethyl 2-[(4-chlorobenzoyl)amino]acetate, 95.0%, 1g

3-Bromo-2,4,6-trimethylaniline>98.0%(GC)(T)5g

Molybdenum foil 99.95% 0.2 x 100 x 200 mm 1 pc

N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N-(2-hydroxy-4-methoxybenzyl)glycine, 97%, 250mg

1,3-Bis(2,6-diisopropylphenyl)imidazolium chloride, 97.0%, 5g

3-Fluoro-2-methylphenol, 98.0%, 1g